AcelRx Pharmaceuticals Inc (ACRX.O)
11.85USD
1 Aug 2013
$0.20 (+1.72%)
$11.65
$11.75
$11.92
$11.73
382,136
660,259
$13.50
$2.27
About
Overall
| Beta: | -- |
| Market Cap (Mil.): | $478.08 |
| Shares Outstanding (Mil.): | 41.04 |
| Dividend: | -- |
| Yield (%): | -- |
Financials
| ACRX.O | Industry | Sector | |
|---|---|---|---|
| P/E (TTM): | -- | 47.13 | 37.76 |
| EPS (TTM): | -1.48 | -- | -- |
| ROI: | -123.92 | -2.58 | 18.76 |
| ROE: | -237.06 | -2.66 | 19.59 |
AcelRX post-op pain treatment meets late-stage study goal
- AcelRX Pharmaceuticals Inc said its experimental treatment for post-operative pain met its main goal in a late-stage trial of patients who had undergone knee or hip replacement surgery, sending its shares up 15 percent.
UPDATE 1-Higher dose of AcelRx pain drug meets trial goal
* AcelRx says 20 mcg dose not better than placebo in mid-stage trial
AcelRx pain drug shows mixed results in mid-stage trial
April 24 - AcelRx Pharmaceuticals Inc said a mid-stage trial of its experimental pain drug showed that a higher dose of the therapy met the main goal of reducing acute pain in patients, but the lower dose failed to meet the goal.
AcelRx post-operative pain treatment meets late-stage study goal
- AcelRx Pharmaceuticals Inc said its experimental drug-device combination to manage post-operative pain met the main goal of a late-stage study on patients who have undergone major open abdominal surgery.
AcelRx pain treatment meets late-stage study goal
- AcelRx Pharmaceuticals Inc said its experimental drug-device combination for post-operative pain met the main goal of a late-stage study on patients who have undergone major open abdominal surgery.
Earnings vs.
Estimates
Analyst Research Reports
| Report Title | Price |
|---|---|
|
Provider: Thomson Reuters Stock Report
|
$25.00
|
|
Provider: Wright Reports
|
$449.00
|
|
Provider: Pechala's Reports
|
$15.00
|
|
Provider: Reuters Investment Profile
|
$20.00
|
|
Provider: Zacks Investment Research Inc.
|
$12.00
|
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

